TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12457302

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 100 mg, 300 mg, or 500 mg administered as a single dose or daily for 10 consecutive days
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: PFA-100
Number of subjects: 113
Study: 10527076

Group type: EXPERIMENTAL
Intervention: 10-week program of muscle strengthening and physical conditioning (3 days/week)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 13
Study: 7594162

Group type: EXPERIMENTAL
Intervention: Vitamin D (ergocalciferol)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 1659495

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Verapamil SR
Number of subjects: 43
Study: 7030855

Group type: COMPARATOR
Intervention: GIK (glucose-insulin-potassium)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: GIK + Verapamil (50 mg continuous drip)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: GIK + Digoxin (0.25 mg b.i.d.)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: GIK + Verapamil + Digoxin
Number of subjects: 100
Study: 6705802

Group type: EXPERIMENTAL
Intervention: Mobile Intensive Care Unit (MICU) manned by paramedics 24/7 and part-time by CCU nurses, dispatched to all suspected emergencies.
Number of subjects: 181

Group type: COMPARATOR
Intervention: Mobile Coronary Care Unit (MCCU) manned by two CCU nurses and two ambulance drivers, operational on workdays from 08:00 to 17:00.
Number of subjects: 181
Study: 29519378

Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stents (ZES)
Number of subjects: 1811

Group type: COMPARATOR
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 1811
Study: 26884592

Group type: EXPERIMENTAL
Intervention: 5 × 5 Gy and three cycles of FOLFOX4 (group A)
Number of subjects: 515

Group type: COMPARATOR
Intervention: 50.4 Gy in 28 fractions combined with two 5‐day cycles of bolus 5‐Fu 325 mg/m(2)/day and leucovorin 20 mg/m(2)/day during the first and fifth week of irradiation along with five infusions of oxaliplatin 50 mg/m(2) once weekly (group B)
Number of subjects: 515
Study: 25225081

Group type: EXPERIMENTAL
Intervention: Cinacalcet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23171211

Group type: EXPERIMENTAL
Intervention: Topical corticosteroids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20860447

Group type: EXPERIMENTAL
Intervention: Intraoperative wound infiltration with 150 mL ropivacaine (2 mg/mL), 1 mL ketorolac (30 mg/mL), and 0.5 mL epinephrine (1 mg/mL) combined with intraarticular infusion (4 mL/h) of 190 mL ropivacaine (2 mg/mL) plus 2 mL ketorolac (30 mg/mL) (group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Epidural infusion (4 mL/h) of 192 mL ropivacaine (2 mg/mL) combined with 6 intravenous administrations of 0.5 mL ketorolac (30 mg/mL) for 48 h postoperatively (group E)
Number of subjects: 40
Study: 18647201

Group type: EXPERIMENTAL
Intervention: EMD
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: GTR
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: EMD+GTR
Number of subjects: 38

Group type: COMPARATOR
Intervention: OFD
Number of subjects: 38
Study: 16042229

Group type: EXPERIMENTAL
Intervention: MSQoL-54
Number of subjects: 215
Study: 12425407

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine gluconate (Peridex)
Number of subjects: 561

Group type: COMPARATOR
Intervention: Listerine (control)
Number of subjects: 561
Study: 10529932

Group type: EXPERIMENTAL
Intervention: 2.0% dorzolamide/0.5% timolol fixed combination (COSOPT)
Number of subjects: 190

Group type: COMPARATOR
Intervention: 0.5% timolol plus 2.0% pilocarpine
Number of subjects: 190
Study: 7724111

Group type: EXPERIMENTAL
Intervention: Oral sulindac (200 mg, once orally every 12 hours for 7 days)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo (once orally every 12 hours for 7 days)
Number of subjects: 69
Study: 1924952

Group type: EXPERIMENTAL
Intervention: Ticlopidine (250 mg/day)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 179
Study: 6259918

Group type: EXPERIMENTAL
Intervention: C-terminal octapeptide of cholecystokinin (4 ng/kg/min)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 12
Study: 30564928

Group type: EXPERIMENTAL
Intervention: Alpha lipoic acid (ALA), oral, twice daily for 6 weeks
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo, twice daily for 6 weeks
Number of subjects: 102
Study: 28941056

Group type: EXPERIMENTAL
Intervention: SMS text messaging intervention
Number of subjects: 314

Group type: COMPARATOR
Intervention: No SMS text messaging (Control)
Number of subjects: 314
Study: 24753120

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) + self-help
Number of subjects: 45

Group type: COMPARATOR
Intervention: Psychoeducation + self-help
Number of subjects: 45
Study: 23806258

Group type: EXPERIMENTAL
Intervention: AAA simulation course with dedicated vascular surgery faculty instruction (Group B, n = 10)
Number of subjects: 18

Group type: COMPARATOR
Intervention: AAA simulation course with surgical skills lab coordinator instruction (Group A, n = 8)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 18
Study: 21093861

Group type: EXPERIMENTAL
Intervention: Elevated serum PAPP‐A (≥4mIU/L)
Number of subjects: 4243
Study: 19940476

Group type: EXPERIMENTAL
Intervention: Hydrofluoric acid (HF) 0.2%, pH 2.0
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Stannous fluoride (SnF(2)) 0.78%, pH 2.9
Number of subjects: 103
Study: 18007129

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral contraceptive pill
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diet and exercise
Number of subjects: 0
Study: 15207837

Group type: EXPERIMENTAL
Intervention: 100 mg sildenafil
Number of subjects: 282

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 282
Study: 12640223

Group type: EXPERIMENTAL
Intervention: Amitriptyline (AMI)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Paroxetine (PAROX)
Number of subjects: 94
Study: 10082152

Group type: EXPERIMENTAL
Intervention: 10 mg oral glibenclamide
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 7560608

Group type: EXPERIMENTAL
Intervention: Quinidine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sotalol
Number of subjects: 50
Study: 1778860

Group type: EXPERIMENTAL
Intervention: Erythromycin (200 mg daily for neonates, 1000 mg daily for adults)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Roxithromycin (50 mg daily for neonates, 300 mg daily for adults)
Number of subjects: 55
Study: 6753547

Group type: EXPERIMENTAL
Intervention: Salbutamol (4 to 8 mg, orally administered)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 31891790

Group type: EXPERIMENTAL
Intervention: Standardised communication
Number of subjects: 16

Group type: COMPARATOR
Intervention: Closed-loop communication
Number of subjects: 16
Study: 29095417

Group type: EXPERIMENTAL
Intervention: Web-based multimedia patient engagement program (Emmi Solutions)
Number of subjects: 0
Study: 26614573

Group type: EXPERIMENTAL
Intervention: Parent involvement in cognitive behavioral therapy (CBT)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Parent involvement in therapy
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Therapist involvement in therapy
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Parent and therapist perspectives
Number of subjects: 24
Study: 24651665

Group type: EXPERIMENTAL
Intervention: Dynamic contrast-enhanced perfusion
Number of subjects: 59
Study: 22699670

Group type: EXPERIMENTAL
Intervention: Interceptive Orthodontics (IO) followed by Observation (OBS)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Comprehensive Orthodontics (CO)
Number of subjects: 170
Study: 20186874

Group type: EXPERIMENTAL
Intervention: Group 'ds+hrHPV': high‐risk HPV facts and de‐stigmatising components
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Group 'lr+hrHPV': low‐risk and high‐risk HPVs facts
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Group 'hrHPV': high‐risk HPV facts only
Number of subjects: 294

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 294
Study: 18063209

Group type: EXPERIMENTAL
Intervention: Plain 1% lidocaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: 2% lidocaine diluted with saline
Number of subjects: 40
Study: 15741830

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (IB) 500 microg
Number of subjects: 13

Group type: COMPARATOR
Intervention: 0.9% NaCl (placebo)
Number of subjects: 13

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 13
Study: 11999609

Group type: EXPERIMENTAL
Intervention: Dopamine infusion (2.5, 5.0, and 7.5 microg kg(‐1) min(‐1))
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Clonidine (150 microg intravenously) given during dopamine infusion (7.5 microg kg(‐1) min(‐1))
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Clonidine (150 microg intravenously) given 15 min before dopamine infusion
Number of subjects: 9
Study: 9431333

Group type: EXPERIMENTAL
Intervention: Clinical direct reports encouraging the consideration of peritoneal dialysis
Number of subjects: 152

Group type: COMPARATOR
Intervention: Usual information without clinical direct reports
Number of subjects: 152
Study: 8208677

Group type: EXPERIMENTAL
Intervention: GenHevac B vaccine (20 micrograms)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Hevac B vaccine (5 micrograms)
Number of subjects: 120
Study: 2684077

Group type: EXPERIMENTAL
Intervention: methylprednisolone acetate (20 mg) intrabursal injection and oral naproxen (1 g/d for 10 days)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: methylprednisolone acetate (20 mg) intrabursal injection and oral placebo for 10 days
Number of subjects: 42

Group type: COMPARATOR
Intervention: oral naproxen (1 g/d for 10 days)
Number of subjects: 42

Group type: COMPARATOR
Intervention: oral placebo for 10 days
Number of subjects: 42
Study: 4875006

Group type: EXPERIMENTAL
Intervention: Neomycin (2 g orally daily)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Neomycin
Number of subjects: 5
Study: 30113425

Group type: COMPARATOR
Intervention: 3 interruptions
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 12 interruptions
Number of subjects: 70
Study: 30698725

Group type: COMPARATOR
Intervention: Carbohydrate (CHO) 0 g protein
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Milk protein (MILK) 20 g
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Whey protein (WHEY) 20 g
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Micellar casein protein (CASEIN) 20 g
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Protein (MILK, WHEY, CASEIN pooled)
Number of subjects: 48
Study: 29349988

Group type: COMPARATOR
Intervention: Patient-Controlled Intravenous Analgesia (PCIA) with controlled instillation of sufentanil
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Multimodal analgesia including continuous femoral nerve block, local injection of knee joint, and buprenorphine patches
Number of subjects: 40
Study: 26479485

Group type: EXPERIMENTAL
Intervention: Manual-based multimodal treatment (MT)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 112
Study: 23307488

Group type: EXPERIMENTAL
Intervention: 10-week aerobic training program (3 sessions/week, 30-40 min at 55-65% peak heart rate)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study: 22124031

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS + Occupational Therapy (OT) for 5 consecutive days (30 minutes each session)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham tDCS + Occupational Therapy (OT)
Number of subjects: 0
Study: 18325821

Group type: EXPERIMENTAL
Intervention: Dysport (40, 80, and 120 units/eye)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dysport (80 units/eye)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16536811

Group type: EXPERIMENTAL
Intervention: 2-week interval treatment with pulsed-dye laser (PDL)
Number of subjects: 15

Group type: COMPARATOR
Intervention: 6-week interval treatment with pulsed-dye laser (PDL)
Number of subjects: 15
Study: 14514628

Group type: EXPERIMENTAL
Intervention: Lipid infusion
Number of subjects: 21
Study: 15374046

Group type: EXPERIMENTAL
Intervention: Hip protector (pads) worn by residents for 9 months
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group (no hip protector)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Hip protector (pads) worn by residents
Number of subjects: 71
Study: 9221571

Group type: EXPERIMENTAL
Intervention: Human insulin (group A)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Human insulin (group B)
Number of subjects: 47
Study: 7963115

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 3623783

Group type: EXPERIMENTAL
Intervention: HR combined with RPE
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: HR alone
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 24
Study: 29723235

Group type: EXPERIMENTAL
Intervention: Anma therapy (AMT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No Anma therapy (no-AMT)
Number of subjects: 40
Study: 27157890

Group type: EXPERIMENTAL
Intervention: EORTC QLQ-BM22
Number of subjects: 204
Study: 26407218

Group type: EXPERIMENTAL
Intervention: Diluted lemon juice (G0)
Number of subjects: 630

Group type: EXPERIMENTAL
Intervention: Full-fat milk (G1)
Number of subjects: 630

Group type: COMPARATOR
Intervention: No intervention (Control group, G2)
Number of subjects: 630
Study: 23616159

Group type: EXPERIMENTAL
Intervention: Frequent syncope (≥5/lifetime)
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Orthostatic intolerance
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Migraine diagnosis
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Frequent syncope and orthostatic intolerance
Number of subjects: 431
Study: 21786434

Group type: EXPERIMENTAL
Intervention: Cilostazol pretreatment (200 mg/day for 7 days)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no cilostazol pretreatment)
Number of subjects: 120
Study: 19368659

Group type: EXPERIMENTAL
Intervention: MRI after ingestion of 800 mL meal
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: MRI after ingestion of 200 mL meal
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Breath test (BT) after ingestion of 200 mL meal
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Breath test (BT) after ingestion of 800 mL meal
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Barostat measurements
Number of subjects: 16
Study: 17077429

Group type: EXPERIMENTAL
Intervention: Individual music therapy plus standard care
Number of subjects: 81

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 81
Study: 15080785

Group type: EXPERIMENTAL
Intervention: Raloxifene 120 mg/day
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 11189687

Group type: EXPERIMENTAL
Intervention: Screening intervention
Number of subjects: 74000

Group type: COMPARATOR
Intervention: Nonscreened control
Number of subjects: 74000
Study: 9065193

Group type: EXPERIMENTAL
Intervention: 20 ml of 0.4% chlorhexidine
Number of subjects: 947

Group type: COMPARATOR
Intervention: 20 ml of sterile water (placebo)
Number of subjects: 947
Study: 8055498

Group type: EXPERIMENTAL
Intervention: Counter-rotational powered brush
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional methods
Number of subjects: 0
Study: 3578969

Group type: EXPERIMENTAL
Intervention: Succinylcholine-assisted intubation (SAI)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Blind nasotracheal intubation (BNI)
Number of subjects: 52
Study: 29277353

Group type: EXPERIMENTAL
Intervention: PHiD-CV 4-dose vial (with preservative)
Number of subjects: 320

Group type: COMPARATOR
Intervention: PHiD-CV 1-dose vial (preservative-free)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Both groups (PHiD-CV 4-dose and 1-dose)
Number of subjects: 320
Study: 26527245

Group type: EXPERIMENTAL
Intervention: Patient-rated personal recovery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patient-rated clinical recovery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Staff-rated clinical recovery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HHI, CANSAS-P, and HoNOS
Number of subjects: 0
Study: 24797544

Group type: EXPERIMENTAL
Intervention: Hydrogel ocular bandage (HOB) applied to the corneal incision at the end of the surgery
Number of subjects: 30

Group type: COMPARATOR
Intervention: No hydrogel ocular bandage (Control group)
Number of subjects: 30
Study: 22682536

Group type: COMPARATOR
Intervention: ULLIN
Number of subjects: 413

Group type: COMPARATOR
Intervention: TLLIN+IRS
Number of subjects: 413

Group type: COMPARATOR
Intervention: ULLIN+CTPS
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: TLLIN
Number of subjects: 413
Study: 20306128

Group type: EXPERIMENTAL
Intervention: Postmastectomy radiation therapy (PMRT)
Number of subjects: 1818

Group type: COMPARATOR
Intervention: Mastectomy alone
Number of subjects: 1818
Study: 18356694

Group type: EXPERIMENTAL
Intervention: Clopidogrel plus tirofiban infusion administered together during inclusion (n = 10)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Clopidogrel administered at inclusion and followed 2 hours after by tirofiban (n = 7)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Clopidogrel plus tirofiban infusion (group A)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Clopidogrel administered at inclusion and followed 2 hours after by tirofiban (group B)
Number of subjects: 17
Study: 15978308

Group type: COMPARATOR
Intervention: Control (treatment A): intact tablet with 120 mL water
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Treatment B: crushed tablet mixed with 4 oz applesauce
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Treatment C: crushed tablet mixed with 120 mL of a common ENF
Number of subjects: 10
Study: 14613023

Group type: EXPERIMENTAL
Intervention: Anastrozole (1 mg once daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tamoxifen (20 mg once daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of Anastrozole plus Tamoxifen
Number of subjects: 0
Study: 10356087

Group type: EXPERIMENTAL
Intervention: 500-microgram phylloquinone tablet
Number of subjects: 11

Group type: COMPARATOR
Intervention: 150 g of raw spinach
Number of subjects: 11

Group type: COMPARATOR
Intervention: 50 g of spinach
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Fresh spinach, fresh broccoli, fresh romaine lettuce
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Fresh or cooked broccoli, fresh romaine lettuce with meals containing 30 or 45% energy as fat
Number of subjects: 11
Study: 8966494

Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D supplements (1.2 g of calcium and 800 IU of vitamin D3)
Number of subjects: 3270

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3270
Study: 8403654

Group type: EXPERIMENTAL
Intervention: Debridement and intravenous antibiotics for four weeks
Number of subjects: 52

Group type: COMPARATOR
Intervention: Debridement, gentamicin-polymethylmethacrylate (Septopal) beads, and perioperative broad-spectrum parenteral antibiotics
Number of subjects: 52
Study: 4030862

Group type: EXPERIMENTAL
Intervention: Repair followed by splinting in abduction
Number of subjects: 89

Group type: COMPARATOR
Intervention: Repair followed by resting the arm at the side
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Excision of the coraco-acromial ligament
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Patients less than 60 years old
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Patients over 60 years old
Number of subjects: 89
Study: 30205658

Group type: EXPERIMENTAL
Intervention: Resistance followed by endurance training (ER, n = 12)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Endurance training followed by resistance training (RE, n = 12)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Interval resistance-endurance training (INT, n = 12)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (Con, n = 12)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combined training within the SE, ES and INT groups
Number of subjects: 40
Study: 27220350

Group type: EXPERIMENTAL
Intervention: CPAP with heated humidification
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional CPAP
Number of subjects: 20
Study: 24607303

Group type: EXPERIMENTAL
Intervention: Brazil nuts (20 g)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Brazil nuts (50 g)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Brazil nuts (0 g)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Brazil nuts (5 g)
Number of subjects: 10
Study: 22781770

Group type: EXPERIMENTAL
Intervention: Fast-track surgery
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 70
Study: 20462352

Group type: EXPERIMENTAL
Intervention: Daptomycin (6 mg/kg daily)
Number of subjects: 108
Study: 18709519

Group type: EXPERIMENTAL
Intervention: Noncontrast helical computed tomography (CT) for diagnosis of ureterolithiasis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Initial management concepts including effective pain control
Number of subjects: 0
Study: 15834081

Group type: EXPERIMENTAL
Intervention: bimatoprost 0.03% combined with latanoprost 0.005% in case eyes
Number of subjects: 18

Group type: COMPARATOR
Intervention: latanoprost 0.005% in control eyes
Number of subjects: 18
Study: 12186576

Group type: EXPERIMENTAL
Intervention: Cooperative-learning program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Social-contact program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no classroom contact)
Number of subjects: 0
Study: 10469695

Group type: EXPERIMENTAL
Intervention: Transfundal route (Veress needle inserted through the uterine fundus)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Infra‐umbilical route
Number of subjects: 100
Study: 8683548

Group type: EXPERIMENTAL
Intervention: Serratia marcescens strains isolated from contact lenses
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Serratia marcescens strains isolated from eyes and other sources
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Serratia marcescens strains from contact lenses
Number of subjects: 12